Overview

An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

Status:
Completed
Trial end date:
2017-12-21
Target enrollment:
Participant gender:
Summary
This study is designed to describe asenapine prescribing patterns in the United Kingdom (UK) during the post-approval period under conditions of usual practice. The use of asenapine in Bipolar Disorder and other indications will be described. To provide epidemiological and clinical perspective, use of aripiprazole and other comparator drugs will be described.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Amisulpride
Aripiprazole
Asenapine
Clozapine
Iloperidone
Lurasidone Hydrochloride
Olanzapine
Paliperidone Palmitate
Quetiapine Fumarate
Risperidone
Sertindole
Sulpiride
Sultopride
Ziprasidone
Zotepine